291 related articles for article (PubMed ID: 10945874)
1. Diadenosine polyphosphates cause contraction and relaxation in isolated rat resistance arteries.
Steinmetz M; Schlatter E; Boudier HA; Rahn KH; De Mey JG
J Pharmacol Exp Ther; 2000 Sep; 294(3):1175-81. PubMed ID: 10945874
[TBL] [Abstract][Full Text] [Related]
2. Heterogenous vascular effects of AP5A in different rat resistance arteries are due to heterogenous distribution of P2X and P2Y(1) purinoceptors.
Steinmetz M; Bierer S; Hollah P; Rahn KH; Schlatter E
J Pharmacol Exp Ther; 2000 Sep; 294(3):1182-7. PubMed ID: 10945875
[TBL] [Abstract][Full Text] [Related]
3. Vasoactivity of diadenosine polyphosphates in human small mesenteric resistance arteries.
Steinmetz M; Janssen AK; Pelster F; Rahn KH; Schlatter E
J Pharmacol Exp Ther; 2002 Aug; 302(2):787-94. PubMed ID: 12130745
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of diadenosine polyphosphates (Ap(n)As), adenosine polyphospho guanosines (Ap(n)Gs) and guanosine polyphospho guanosines (Gp(n)Gs) at P2 receptors in the rat mesenteric arterial bed.
Ralevic V; Jankowski J; Schlüter H
Br J Pharmacol; 2001 Nov; 134(5):1073-83. PubMed ID: 11682456
[TBL] [Abstract][Full Text] [Related]
5. Dependence of P2-nucleotide receptor agonist-mediated endothelium-independent relaxation on ectonucleotidase activity and A2A-receptors in rat portal vein.
Guibert C; Loirand G; Vigne P; Savineau JP; Pacaud P
Br J Pharmacol; 1998 Apr; 123(8):1732-40. PubMed ID: 9605582
[TBL] [Abstract][Full Text] [Related]
6. Pivotal role of phosphate chain length in vasoconstrictor versus vasodilator actions of adenine dinucleotides in rat mesenteric arteries.
Ralevic V; Hoyle CH; Burnstock G
J Physiol; 1995 Mar; 483 ( Pt 3)(Pt 3):703-13. PubMed ID: 7776252
[TBL] [Abstract][Full Text] [Related]
7. Purinoceptor subtypes mediating contraction and relaxation of marmoset urinary bladder smooth muscle.
McMurray G; Dass N; Brading AF
Br J Pharmacol; 1998 Apr; 123(8):1579-86. PubMed ID: 9605564
[TBL] [Abstract][Full Text] [Related]
8. Vasoactivity of diadenosine polyphosphates in human small renal resistance arteries.
Steinmetz M; Gabriëls G; Le TV; Piechota HJ; Rahn KH; Schlatter E
Nephrol Dial Transplant; 2003 Dec; 18(12):2496-504. PubMed ID: 14605271
[TBL] [Abstract][Full Text] [Related]
9. Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vessels.
Ziganshin AU; Hoyle CH; Lambrecht G; Mutschler E; Bümert HG; Burnstock G
Br J Pharmacol; 1994 Mar; 111(3):923-9. PubMed ID: 8019770
[TBL] [Abstract][Full Text] [Related]
10. Multiple P2Y receptors mediate contraction in guinea pig mesenteric vein.
Mutafova-Yambolieva VN; Carolan BM; Harden TK; Keef KD
Gen Pharmacol; 2000 Feb; 34(2):127-36. PubMed ID: 10974420
[TBL] [Abstract][Full Text] [Related]
11. Relative contribution of P2U- and P2Y-purinoceptors to endothelium-dependent vasodilatation in the golden hamster isolated mesenteric arterial bed.
Ralevic V; Burnstock G
Br J Pharmacol; 1996 Apr; 117(8):1797-802. PubMed ID: 8732294
[TBL] [Abstract][Full Text] [Related]
12. Evidence for two different P2X-receptors mediating vasoconstriction of Ap5A and Ap6A in the isolated perfused rat kidney.
van der Giet M; Cinkilic O; Jankowski J; Tepel M; Zidek W; Schlüter H
Br J Pharmacol; 1999 Jul; 127(6):1463-9. PubMed ID: 10455297
[TBL] [Abstract][Full Text] [Related]
13. Influence of purinoceptor antagonism on diadenosine pentaphosphate-induced hypotension in anesthetized rats.
Steinmetz M; van Le T; Hollah P; Gabriëls G; Hohage H; Rahn KH; Schlatter E
J Pharmacol Exp Ther; 2000 Sep; 294(3):963-8. PubMed ID: 10945847
[TBL] [Abstract][Full Text] [Related]
14. The interaction of diadenosine polyphosphates with P2x-receptors in the guinea-pig isolated vas deferens.
Westfall TD; McIntyre CA; Obeid S; Bowes J; Kennedy C; Sneddon P
Br J Pharmacol; 1997 May; 121(1):57-62. PubMed ID: 9146887
[TBL] [Abstract][Full Text] [Related]
15. Effects of diadenosine polyphosphates (Ap(n)As) and adenosine polyphospho guanosines (Ap(n)Gs) on rat mesenteric artery P2X receptor ion channels.
Lewis CJ; Gitterman DP; Schlüter H; Evans RJ
Br J Pharmacol; 2000 Jan; 129(1):124-30. PubMed ID: 10694211
[TBL] [Abstract][Full Text] [Related]
16. Characterization and distribution of P2-purinoceptor subtypes in rat pulmonary vessels.
Liu SF; McCormack DG; Evans TW; Barnes PJ
J Pharmacol Exp Ther; 1989 Dec; 251(3):1204-10. PubMed ID: 2600811
[TBL] [Abstract][Full Text] [Related]
17. Effects of adenosine 5'-triphosphate, uridine 5'-triphosphate, adenosine 5'-tetraphosphate and diadenosine polyphosphates in guinea-pig taenia caeci and rat colon muscularis mucosae.
Hourani SM; Bailey SJ; Johnson CR; Tennant JP
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):464-73. PubMed ID: 9826069
[TBL] [Abstract][Full Text] [Related]
18. Role of the purinergic and noradrenergic components in the potentiation by endothelin-1 of the sympathetic contraction of the rabbit central ear artery during cooling.
García-Villalón AL; Padilla J; Monge L; Fernández N; Gómez B; Diéguez G
Br J Pharmacol; 1997 Sep; 122(1):172-8. PubMed ID: 9298544
[TBL] [Abstract][Full Text] [Related]
19. Diadenosine polyphosphate analog controls postsynaptic excitation in CA3-CA1 synapses via a nitric oxide-dependent mechanism.
Melnik S; Wright M; Tanner JA; Tsintsadze T; Tsintsadze V; Miller AD; Lozovaya N
J Pharmacol Exp Ther; 2006 Aug; 318(2):579-88. PubMed ID: 16709679
[TBL] [Abstract][Full Text] [Related]
20. Coronary response to diadenosine pentaphosphate after ischaemia-reperfusion in the isolated rat heart.
García-Villalón AL; Monge L; Fernández N; Salcedo A; Narváez-Sánchez R; Diéguez G
Cardiovasc Res; 2009 Feb; 81(2):336-43. PubMed ID: 19029135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
